Growth hormone-induced blood pressure decrease is associated with increased mRNA levels of the vascular smooth muscle KATP channel

Journal of Endocrinology

Volumn 183, Issue 1, 2004, Pages 195-202

  Tivesten, Åsa ^a   Barlind, Anna ^a   Caidahl, Kenneth ^a   Klintland, Natalia ^a   Cittadini, Antonio ^b   Ohlsson, Claes ^a   Isgaard, Jörgen ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HUMAN GROWTH HORMONE; INWARDLY RECTIFYING POTASSIUM CHANNEL; MESSENGER RNA; POTASSIUM CHANNEL; SODIUM CHLORIDE; SULFONYLUREA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY COMPLIANCE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DRUG MECHANISM; GENE EXPRESSION; GROWTH HORMONE DEFICIENCY; HEART OUTPUT; HORMONE ACTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MICROARRAY; RAT; RAT STRAIN; REGULATORY MECHANISM; SYSTOLIC BLOOD PRESSURE; UPREGULATION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; AORTA; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD PRESSURE; CARDIAC OUTPUT; GENE EXPRESSION; HUMAN GROWTH HORMONE; HYPOPHYSECTOMY; MALE; MICROARRAY ANALYSIS; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; RECOMBINANT PROTEINS; RNA, MESSENGER; SYSTOLE; VASCULAR RESISTANCE;

EID: 12344268065     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05726     Document Type: Article

References (33)

1. Baily RG, Lehman JC, Gubin SS & Musch TI 1993 Non-invasive assessment of ventricular damage in rats with myocardial infarction. Cardiovascular Research 27 851-855.
2. Barreto-Filho JA, Alcantara MR, Salvatori R, Barreto MA, Sousa AC, Bastos V, Souza AH, Pereira RM, Clayton PE, Gill MS et al. 2002 Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. Journal of Clinical Endocrinology and Metabolism 87 2018-2023.
3. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A & Frolich JC 1996 Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. Journal of Clinical Investigation 98 2706-2713.
4. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S & Sacca L 2001 Abnormal vascular reactivity in growth hormone deficiency. Circulation 103 520-524.
5. Castillo C, Cruzado M, Ariznavarreta C, Gil-Loyzaga P, Lahera V, Cachofeiro V & Tresguerres JA 2003 Body composition and vascular effects of growth hormone administration in old female rats. Experimental Gerontology 38 971-979.
6. Christensen KL, Mulvany MJ & Jespersen LT 1990 Can mean arterial pressure be estimated from measurements of systolic and diastolic blood pressure, and vice versa? Journal of Hypertension 8 321-326.
7. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP & Douglas PS 1996 Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat. A combined in vivo and in vitro evaluation. Circulation 93 800-809.
8. Clemow DB, Steers WD & Tuttle JB 2000 Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats. Journal of Cellular Physiology 183 289-300.
9. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW & Milstone DS 2001 A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. Journal of Clinical Investigation 107 1255-1262.
10. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L & Madeddu P 2002 Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106 2257-2262.
11. Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, Frenneaux MP, Rees A & Scanlon MF 2000 The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. European Journal of Endocrinology 142 254-262.
12. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B, Longobarch S, Lombardi G & Sacca L 1997 Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. European Heart Journal 18 340-347.
13. Fujii K, Onaka U, Goo K, Abe I & Fujishima M 1999 Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats. Hypertension 34 222-228.
14. Fujita A & Kurachi Y 2000 Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers. Pharmacology and Therapeutics 85 39-53.
15. Goffin V, Shiverick KT, Kelly PA & Martial JA 1996 Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocrine Reviews 17 385-410.
16. Hasdai D, Rizza RA, Holmes DR Jr, Richardson DM, Cohen P & Lerman A 1998 Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension 32 228-234.
17. He NG, Awasthi S, Singhal SS, Trent MB & Boor PJ 1998 The role of glutathione S-transferases as a defence against reactive electrophiles in the blood vessel wall. Toxicology and Applied Pharmacology 152 83-89.
18. Isgaard J, Bergh CH, Caidahl K, Lomsky M, Hjalmarson A & Bengtsson BA 1998 A placebo-controlled study of growth hormone in patients with congestive heart failure. European Heart Journal 19 1704-1711.
19. Kunsch C & Medford RM 1999 Oxidative stress as a regulator of gene expression in the vasculature. Circulation Research 85 753-766.
20. Longobardi S, Cittadini A, Stromer H, Katz SE, Grossman JD, Clark RG, Morgan JP & Douglas PS 2000 Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats. Growth Hormone and IGF Research 10 242-247.
21. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H & Seino S 2002 Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nature Medicine 8 466-472.
22. Mills DE & Woods RB 1985 Interaction of prolactin with adrenal hormones in blood pressure regulation in rats. American Journal of Physiology 249 E614-E618.
23. Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P & Clayton RN 1999 Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 84 453-457.
24. Ringqvist A, Caidahl K, Petersson AS & Wennmalm A 2000 Diurnal variation of flow-mediated vasodilation in healthy premenopausal women. American Journal of Physiology Heart and Circulatory Physiology 279 H2720-H2725.
25. Rosen T & Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336 285-288.
26. Rossoni G, Locatelli V, De Gennaro Colonna V, Torsello A, Schweiger F, Boghen M, Nilsson M, Bernareggi M, Muller EE & Berti F 1999 Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat. Journal of Cardiovascular Pharmacology 34 454-460.
27. Safar ME, Levy BI & Struijker-Boudier H 2003 Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107 2864-2869.
28. Scarisbrick IA, Jones EG & Isackson PJ 1993 Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. Journal of Neuroscience 13 875-893.
29. Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF & Davies JS 2002 Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clinical Endocrinology 56 493-501.
30. Ting AY & Endy D 2002 Signal transduction. Decoding NF-kappaB signaling. Science 298 1189-1190.
31. Tivesten A, Caidahl K, Kujacic V, Sun XY, Hedner T, Bengtsson BA & Isgaard J 2001 Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Hormone and IGF Research 11 187-195.
32. Tivesten A, Bollano E, Andersson I, Fitzgerald S, Caidahl K, Sjogren K, Skott O, Liu JL, Mobini R, Isaksson OG et al. 2002 Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143 4235-4242.
33. Zettler C, Head RJ & Rush RA 1991 Chronic nerve growth factor treatment of normotensive rats. Brain Research 538 251-262.